focus -WSS

focus

author：entertainment 2025-09-28 21:05:36 - browse：2

Fran van Delft for Galapagos

Seeking to differentiate itself from other makers of CAR-T cancer therapies, Galapagos NV on Wednesday announced it had struck a deal with Blood Centers of America to open up dozens of manufacturing sites for its cell-based medicines around the U.S.

Galapagos said it will rely on the partnership, the financial terms of which were not disclosed, as it moves its CAR-Ts for different cancers into pivotal studies and could also help launch those medicines should they win approval. The Belgian company framed the collaboration as one that could help overcome the limitations that have held back access to existing CAR-T therapies from other companies.

CAR-Ts have proven to be potent treatments for certain cancers, but they are complicated medicines to make. Immune cells have to be removed from a patient, shipped to specialty sites, where they’re engineered with cancer-killing abilities, and then returned to the hospital for infusion back into patients. The process, which can take weeks if not months, has put a crunch on the number of patients companies and hospitals are able to treat.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： White House calls on federal agencies to crack down on AI abuses

WSS

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Study: New antibiotic targets gonorrhea as well as last existing drug

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Palantir health business leans on meeting customers’ needs

Excited delirium, Elijah McClain, and emergency physicians

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

Will General Catalyst be the first of many hospital takeovers?

In Memoriam: Notable people who died in 2023

Lecanemab for Alzheimer's is coming. Is the health system ready?

Apple is now the first public company to be valued at $3 trillion

Abortion clinic in Cancun will cater to Americans

What does generative AI mean for health care? We asked experts

More doctors should go into startup world

Wildfire smoke exposes gaps in outdoor worker protections

Why ADHD is under

explore

Abortion clinic in Cancun will cater to Americans

Study: Pain burden is higher in Black NFL players than white ones

Sanofi CEO defends move to abandon profit guidance, boost research

Charles Manson follower Leslie Van Houten released from prison after 53 years

Medicare solvency divides Republicans at the presidential debate

Study: Pain burden is higher in Black NFL players than white ones

explore

explore

focus

leisure time